BMRN News and Press, BioMarin Pharmaceutical Inc.

2026-03-09 10:08:00 ET BioMarin Pharmaceutical Inc. (BMRN) Leerink Global Healthcare Conference 2026 March 9, 2026 8:00 AM EDT... Read the full article on Seeking Alpha For further details see: BioMarin Pharmaceutical Inc. (BMRN) Presents at Leerink Global Healthcare Confere...

2026-03-04 12:42:13 ET BioMarin Pharmaceutical Inc. (BMRN) TD Cowen 46th Annual Health Care Conference March 4, 2026 10:30 AM EST... Read the full article on Seeking Alpha For further details see: BioMarin Pharmaceutical Inc. (BMRN) Presents at TD Cowen 46th Annual Health Ca...

2026-03-03 12:05:28 ET Ascendis Pharma ( ASND ) announced the FDA approval of Yuviwel (navepegritide/TransCon CNP) for the treatment of children with achondroplasia. The regulatory decision comes despite the legal challenges by competitor BioMarin ( BMRN ).... ...

2026-03-03 07:03:37 ET Eliana Merle from Barclays issued a price target of $105.00 for BMRN on 2026-03-03 11:12:00. The adjusted price target was set to $105.00. At the time of the announcement, BMRN was trading at $59.74. The overall price target consensus is at $83.64 ...

2026-03-02 11:03:41 ET Ilya Zubkov from Loop Capital Markets issued a price target of $105.00 for BMRN on 2026-03-02 14:53:00. The adjusted price target was set to $105.00. At the time of the announcement, BMRN was trading at $60.4666. The overall price target consensus ...

U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU) PR Newswire Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone...

BioMarin to Participate in Four Upcoming Investor Conferences in March PR Newswire TD Cowen 46th Annual Health Care Conference on Wednesday, March 4, 2026 Leerink 2026 Global Healthcare Conference on Monday, March 9, 2026 Jefferies 2026 Biotech on the Beach Summit on Tuesda...

2026-02-23 23:15:27 ET More on BioMarin Pharmaceutical BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call Transcript BioMarin Pharmaceutical Inc. 2025 Q4 - Results - Earnings Call Presentation The Right Play On BioMarin Pharmaceuticals BioMarin Pharmac...

2026-02-23 23:14:58 ET BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call February 23, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: BioMarin Pharmaceutical Inc. (BMRN) Q4 2025 Earnings Call Transcript

2026-02-23 16:09:44 ET Read the full article on Seeking Alpha For further details see: BioMarin Pharmaceutical Non-GAAP EPS of $0.46 misses by $0.10, revenue of $875M beats by $39.97M